-
December 7: The Week in Cancer News
A trial tests a new treatment for some patients with early-stage breast cancer, and studies assess how long the benefits of CAR-T cell therapy last for patients with non-Hodgkin lymphoma.
by Kate Yandell
-
November 30: The Week in Cancer News
A study warns that popular YouTube videos about prostate cancer may be misleading, and the U.S. Food and Drug Administration approves a therapy based on tumor genetics, not tumor origin.
by Kate Yandell
-
November 16: The Week in Cancer News
A study links adolescent obesity to adult pancreatic cancer risk, and “Batkid” turns 10 years old.
by Bradley Jones
-
November 9: The Week in Cancer News
A study assesses how timing affects the outcomes of pregnancy after cancer treatment, and researchers present on the benefits of Medicaid expansion for breast cancer patients.
by Kate Yandell
-
November 2: The Week in Cancer News
A survey shows that 39 percent of Americans believe that alternative therapies can cure cancer, and a trial finds that minimally invasive surgery is inferior to traditional surgery for treating cervical cancer.
by Kate Yandell
-
October 26: The Week in Cancer News
Researchers present cancer clinical trial results at the ESMO 2018 Congress, and a study shows that crowdfunding campaigns are raising money for unproven cancer treatments.
by Kate Yandell
-
October 19: The Week in Cancer News
A study investigates cancer care for rural children, and the U.S. Food and Drug Administration approves a new breast cancer therapy.
by Kate Yandell
-
October 12: The Week in Cancer News
A study sheds light on the difficulty patients have in accessing their medical records, and the U.S. Food and Drug Administration expands approval of the human papillomavirus vaccine.
by Kate Yandell
-
October 5: The Week in Cancer News
Cancer immunology researchers are awarded a Nobel Prize, and a seventh immune checkpoint inhibitor is approved by the U.S. Food and Drug Administration.
by Kate Yandell
-
September 28: The Week in Cancer News
A study characterizes “chemo brain” in breast cancer patients treated with chemotherapy, and physicians and scientists gather in Toronto to present their lung cancer research.
by Kate Yandell
Cancer Talk
Family of Henrietta Lacks Works for ‘Health Intelligence’
Alfred Lacks Carter Jr. and other family members honor the legacy of Henrietta Lacks by helping others better understand their health care.
by Kevin McLaughlin
Researchers Tackle Immune-related Adverse EffectsScientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona